Apollo Hospitals Enterprises's intrinsic value using Intellectual Capital analysis

Apollo Hospitals Enterprises

BSE : 508869

|

NSE : APOLLOHOSP

Industry : Hospitals

|

ISIN : INE437A01024

|

FreeFloat : 70.11%

|

FnO : Yes

|

LotSize : 125

BSE SENSEX 50 | Nifty 50 | Nifty50 Equal Weight | BSE 200 | BSE 200 Equal Weight | BSE 250 LargeMidcap | BSE LargeMidcap | Nifty 200 | Nifty LargeMidcap 250 | BSE 100 | BSE 100 Largecap TMC | BSE Largecap | BSE SENSEX Next 30 | BSE SENSEX Next 50 TMC | BSE SENSEX SIXTY | Nifty 100 | Nifty100 Equal Weight | Nifty Alpha Low Volatility 30 | Nifty Healthcare | Nifty500 Healthcare | BSE Dividend Stability | BSE Low Volatility | Nifty Growth Sectors 15 | Nifty Low Volatility 50 | Nifty100 Alpha 30 | Nifty100 Low Volatility 30 | Nifty500 Low Volatility 50 | BSE 100 ESG | Nifty 100 ESG Sector Leaders | Nifty100 Enhanced ESG | Nifty100 ESG | Nifty India Consumption | Nifty Infrastructure | Nifty Services Sector | Nifty500 Multicap Infra 50:30:20

Intellectual Capital (IC)	13,978.51
Net Worth (NW)	8,652.90
Intrinsic Worth (IW)	22,631.41
Market Cap (MC)	95,130.80
Economic Value Added	-47.49

Discount Rate	%
Liquidity Premium	%

Knowledge Basis (IC/IW)	61.77%
IC Gross Margin (EBITDA/IC)	24.57%
IC Net Margin (NPT/IC)	10.98%
Knowledge Turnover (Sales/IC)	1.65
Market to Intrinsic Value (MC/IW)	4.20

As Of	Intrinsic Value	Market Price
31 Mar 2025	Rs. 1,573.98	Rs. 6,616.20
17 Jul 2025	----	Rs. 7,350.50
17 Jul 2025	----	-2.00 -0.03%

Fundamental - Quality		Technical - Daily Price action		Near-term Outlook
EVA > 0 : No	Bearish	10 DMA : Rs. 7,403.55	Bearish	Very Bearish
KB > 50% : Yes		50 DMA : Rs. 7,098.63
0 < M2IV < 1 : No		Vol-Price trend : Falling
Disclaimer: Sentimeter is based on market data calculations and is NOT an investment advice

Question 3 - Is this stock undervalued?

Question 2 - Does this business have significant knowledge assets?

Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)

Quarter

Type*

Sales

Income

EBITDA

EBIT

PBT

PAT

NPT

Jun-22
C
3795.60
3811.66
494.78
347.00
254.28
323.78
323.78

Sep-22
C
4251.07
4273.64
574.78
419.77
327.07
212.84
214.84

Dec-22
C
4263.58
4298.94
519.17
365.78
265.82
162.31
162.66

Mar-23
C
4302.20
4318.55
508.07
349.01
253.60
145.64
145.52

Jun-23
C
4417.80
4446.00
543.10
376.20
270.00
173.40
173.20

Sep-23
C
4846.90
4869.10
651.80
488.40
377.10
248.80
249.20

Dec-23
C
4850.60
4878.40
642.90
475.90
363.30
254.40
254.30

Mar-24
C
4943.90
4972.00
677.20
487.50
368.20
258.40
258.40

Jun-24
C
5085.60
5122.80
723.80
546.40
430.00
315.50
315.50

Sep-24
C
5589.30
5627.50
853.70
669.20
551.70
395.70
395.90

Dec-24
C
5526.90
5590.70
825.30
640.70
530.90
379.40
380.00

Mar-25
C
5592.20
5653.30
830.80
619.80
505.00
414.50
414.40

* C - Consolidated, S - Standalone

Standard Disclaimer

Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
Past performance, by way of backtesting or by way of actuals, is no guarantee of future returms.
Data mentioned on this page is for educational purpose only and does not constitute investment advice.

Standard Warning - Investment in securities markets are subject to market risk. Read all the related documents carefully before investing.